Showing results (81-90 of 96) with videos related to
Sort By:
Pageof 10
Chemical Communications (Cambridge, England)|May 31, 2023
MnFe phosphides doped in hollow Prussian blue analogues with Ru modification as an efficient cathode for Li-O2 batteriesYiru Ma, Huiqi Qu, Huimin Zhao, et al.Breast Cancer (Dove Medical Press)|August 27, 2025
Safety Profile and Predictors of Adverse Events of Incadronate Disodium in Treating Breast Cancer Patients with Bone Metastases: A Retrospective StudyShihan Zhou, Mingxia Jiang, Jiaxuan Liu, et al.European Journal of Radiology|January 20, 2023
Role of iodine density value on dual-energy CT for detection of high tumor cell proportion region in lung cancer during CT-guided transthoracic biopsyYaqiong Ma, Shenglin Li, Gang Huang, et al.Nursing Open|April 4, 2023
Relationship between perceptions of recurrence risk and depression state among first-episode ischemic stroke patients in rural areas: The mediating role of coping styleXueting Liu, Zhenxiang Zhang, Beilei Lin, et al.International Journal of Cancer|July 7, 2018
Toremifene, rather than tamoxifen, might be a better option for the adjuvant endocrine therapy in CYP2D6*10T/T genotype breast cancer patients in ChinaBo Lan, Fei Ma, Shanshan Chen, et al.Breast (Edinburgh, Scotland)|April 27, 2020
Safety and efficacy of sirolimus combined with endocrine therapy in patients with advanced hormone receptor-positive breast cancer and the exploration of biomarkersZongbi Yi, Binliang Liu, Xiaoying Sun, et al.Signal Transduction and Targeted Therapy|July 7, 2021
The molecular tumor burden index as a response evaluation criterion in breast cancerZongbi Yi, Fei Ma, Guohua Rong, et al.Journal of Neuroinflammation|July 19, 2021
Activation of GPR40 attenuates neuroinflammation and improves neurological function via PAK4/CREB/KDM6B pathway in an experimental GMH rat modelJie Xiao, Tao Cai, Yuanjian Fang, et al.Clinical Breast Cancer|January 12, 2019
The Effect of Polymorphism in UGT1A4 on Clinical Outcomes of Adjuvant Tamoxifen Therapy for Patients With Breast Cancer in ChinaBo Lan, Fei Ma, Mei Han, et al.Breast (Edinburgh, Scotland)|April 14, 2026
Association between diarrhea and survival in patients with HER2-positive advanced breast cancer treated with pyrotinib-based therapy: A landmark analysis from the real-world PRETTY studyYiqun Li, Wenna Wang, Zhongsheng Tong, et al.Pageof 10